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Abstract  
 
Background: Light-at-night has been shown in experimental studies to disrupt 
melatonin production but this has only partly been confirmed in studies of night shift 
workers. In this cross-sectional study we examined the circadian variation of melatonin 
in relation to shift status, individual levels of light-at-night exposure and diurnal 
preference, an attribute reflecting personal preference for activity in the morning or 
evening.  
 
Methods: 117 workers (75 night and 42 day) of both sexes, aged 22-64 years, were 
recruited from four companies. Participants collected urine samples from all voids over 
24 hours and wore a data logger continuously recording their light exposure. Socio-
demographic, occupational, lifestyle and diurnal preference information were collected 
by interview. Urinary 6-sulfatoxymelatonin, the main melatonin metabolite, 
concentrations were measured.  
 
Results: Mean 6-sulfatoxymelatonin levels were lower in night (10.9 ng/mg 
creatinine/h; 95% CI, 9.5-12.6) compared to day workers (15.4; 95% CI, 12.3-19.3). 
The lowest 6-sulfatoxymelatonin levels were observed in night workers with morning 
preference (6.4; 95% CI, 3.0-13.6). Peak time of 6-sulfatoxymelatonin production 
occurred 3 hours later in night (08:42 h, 95% CI 07:48-09:42) compared to day workers 
(05:36 h, 95% CI 05:06-06:12). Phase delay was stronger among subjects with higher 
light-at-night exposure and number of nights worked.  
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Conclusions: Night shift workers had lower levels and a delay in peak time of 6-
sulfatoxymelatonin production over a 24 hour period. Differences were modified by 
diurnal preference and intensity of light-at-night exposure. 
 
Impact: Night shift work affects levels and timing of melatonin production and both 
parameters may relate to future cancer risk.  
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INTRODUCTION 
Shift work that involves circadian disruption was classified as a probable 
carcinogen for humans by the International Agency for Research on Cancer (IARC) 
based on sufficient evidence from animal studies and limited evidence in humans (1).  
Circadian disruption and abnormal melatonin production are potential underlying 
biological mechanisms for the increased risk of cancer among night shift workers (1-5). 
Pineal melatonin, a key hormone of the circadian system, has oncostatic properties 
exhibiting antioxidant, antimitotic, antiangiogenic and immunomodulatory activity (3, 
6). Melatonin production typically occurs during the biological night (peak-time 2:00-
4:00 h) and is sensitive to light, the main environmental cue that synchronizes circadian 
rhythms to the 24 hour day (7). In human experimental studies, exposure to light-at-
night suppresses melatonin production in a dose-dependent manner (8-10).  
Urinary levels of 6-sulfatoxymelatonin (aMT6s), the major melatonin 
metabolite, is widely used as a biomarker of circadian phase and disruption. Night shift 
workers are occupationally exposed to light-at-night and experience lower aMT6s levels 
as described in some observational studies, performed mostly among nurses (11-19). To 
date, only a few of these studies have been able to address this issue using objective 
light exposure measurements (12, 15, 16, 18, 19). Furthermore, after several nights 
worked, some night shift workers can adapt to their shift schedule and melatonin peak 
time shifts to coincide with the daytime sleep episode (20-22). In most studies, only 
absolute aMT6s levels were assessed and not peak time of production. Comparisons of 
aMT6s levels based on a single void or limited sampling can be confounded by 
circadian phase differences among individuals (commonly found in shift workers). 
Individual diurnal preference or chronotype is a human attribute with genetic basis that 
reflects the time of the day functions are active (23). Diurnal preference is suggested to 
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affect shift work adaptation (24). Evening types (subjects with a later melatonin peak) 
may adapt faster to night shift work by phase delaying their circadian rhythms (21, 25-
27), but this is still an understudied hypothesis.  
In the present cross-sectional study, we evaluated if permanent night shift 
workers produce less aMT6s compared to day workers over a 24 hour working period. 
We also examined changes in the peak time of urinary aMT6s related with working at 
night. In both comparisons we took into account individual diurnal preference and light 
at night exposure.  
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MATERIALS AND METHODS 
Study population  
Health and Safety department personnel of 4 companies (2 public hospitals, a car 
manufacturer and a railway company) in Barcelona, Spain contacted workers and 
offered them participation in the study. A leaflet with study information and selection 
criteria was handed to all workers doing fixed day and night shifts in each company. 
Subjects were not eligible for participation if they had cancer history, were taking oral 
contraceptives or hormonal therapy or had been pregnant 6 months prior to the study. 
For every two night workers, one day worker from the same company was enrolled as a 
control. 75 night and 42 day workers of both sexes, aged 22-64 years were recruited in 
the study. Among female participants, all but two were hospital shift nurses or 
assistants. Among males, all but four were workers in the car industry or the train 
company. Night shift nurses worked 10 hour fixed shifts (21:00-07:00 h) on a short (2 
days off-2 nights work-3 days off) and a long (2 nights work- 2 days off-3 nights work) 
working week alternately. Night shift car industry workers and train employees 
performed 8 hour shifts (22:00-06:00 h) on a schedule including 3 and 5 consecutive 
nights per week, respectively. All day workers were engaged in fixed 8 hour morning 
shifts 5 days a week with starting times varying from 05:45 to 07:00 h depending on the 
working sector. The study was approved by the local ethics committee and all 
participants signed an informed consent. 
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Data Collection  
Subjects were interviewed and information on occupation (working patterns, night shift 
history), socio-demographics and lifestyle (physical activity, alcohol consumption, 
smoking, sleep habits, medication etc.) was collected. Questions were asked for both 
habitual patterns as well as for the 24 hours previous to the study. Diurnal preference 
was assessed using the self-administered Morningness-Eveningness Questionnaire 
(MEQ) (28). Participants collected samples from all natural urine voids over an 
approximate 24 hour period on a working day. A total of 1030 urine samples, were 
collected in 50 ml plastic tubes, which were labelled with the time and date of each 
collection. Participants were advised to keep the urine samples in a refrigerator 
immediately after collection and send them to the laboratory by courier mail 1 or 2 days 
later. Samples were stored at -80 ºC until analysis. Four subjects with less than 3 urine 
samples collected were excluded from the statistical analysis assuming that these 
individuals were most likely to have missed samples and therefore data would be 
incomplete. The final study population consisted of 72 night and 41 day workers. 
Amean of 7.8 (SD 2.1) urine samples were collected per participant (7.7; SD 2.1 and 
8.0; SD 2.1 among night and day workers respectively). 
 
6-sulfatoxymelatonin (aMT6s) assessment 
Urinary 6-sulfatoxymelatonin (aMT6s) concentrations were measured at the 
Chronobiology Group, University of Surrey, UK, using a radioimmunoassay 
(Stockgrand, Ltd., Guildford, Surrey, UK). Urine samples were analyzed in duplicates 
in 28 assays and all samples of the same subject were included in the same assay. The 
intrassay variability was 5.7% at 3.3 ng/ml, 7.8% at 15.5 ng/ml and 6.1% at 28.3 ng/ml 
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and the limit of detection was 0.2 ng/ml. Interassay variability was 8.7% at 2.6 ng/ml, 
7.9%  at 17.6 ng/ml and 10.3% at 31.3 ng/ml. Creatinine levels were determined in all 
urine samples by the same laboratory using the manual picric acid, sodium hydroxide 
colorimetric method (Randox Laboratories Ltd.) in order to account for dilution 
variability and duration between consecutive samples. Limit of detection of the assay 
was 25.1 mg/dl and interassay variability was 7.6% at 87.4 mg/dl and 9.9% at 198.3 
mg/dl. All creatinine concentrations were adjusted to give mg/ml to allow aMT6s values 
to be quoted as ng/mg creatinine thus giving creatinine-standardized values. 
 
Light exposure assessment 
Participants wore a light intensity data logger (HOBOware, Onset Computer 
Corporation) that continuously (every 12 or 15 seconds) recorded their ambient light 
exposure over an approximate 24 hour period, simultaneously with the urine collections. 
The logger was relatively small in size (5.8 x 3.3 x 2.3 cm) and light in weight (18 g) 
and was carried at the shoulder level. This position was used to obtain measurements 
that would approximate the amount of light reaching the retina. During sleep, 
participants placed the logger on a bedside table with the sensor facing upwards and 
while showering left it nearby in the bathroom. The loggers recorded relative light 
intensity within the range of 0-320,000 lux and were designed for indoor and outdoor 
settings. Recruitment of participants and therefore light measurements took place from 
15th March until 12th June in Barcelona (latitude 41° 23' N, longitude 2° 10' E) therefore 
there was variation in the day length (11.8-15.1 h of sunlight). Mean light-at night 
exposure was calculated over different periods including the period from 24:00 to 05:00 
h (expected time of peak of melatonin), from 22:00 to 07:00 h (approximate darkness 
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window during the study period) and during the working period (using time schedules). 
Morning light exposure immediately after shift work to initiation of sleep was 
additionally evaluated among night shift workers. Zero values (12% of total) were 
replaced by half (5.4 lux) of the lowest value recorded by the sensor (10.8 lux) during 
the night shift to account for intensities below the sensor’s detection limit or for the 
possibility that the sensor was covered by hair or clothes.  
 
Statistical analysis 
Cosinor analysis was used to evaluate the aMT6s rhythm (29). Cosinor analysis is a 
curve fitting procedure that is usually used in circadian and other rhythms with a cyclic 
nature and an approximate 24 hour period. Our analysis followed a two-step approach. 
In the first step, cosinor analysis was used to obtain, for each subject, the derived 
parameters: mesor (circadian mean), amplitude (distance between the maximum and 
mesor) and acrophase (peak time of production). The mesor from the cosinor analysis is 
proportional to the area under the curve (AUC=mesor*24). Two ‘goodness of fit’ 
measures were used to determine the validity of the cosinor-derived parameters: the 
percentage variability accounted for the cosine curve and the p-value for the null 
hypothesis of no cosine rhythm in the data. In the second step, we calculated geometric 
means and 95% confidence intervals (95% CI) for each aMT6s cosinor parameter 
(mesor, amplitude, acrophase) by shift work status in the study population and also by 
sex. Linear regression analysis was used to evaluate the association between log-
transformed aMT6s cosinor parameters and shift work status. Log-transformation was 
applied to achieve a normal distribution.  For aMT6s levels regression estimates were 
back-transformed and presented as the geometric mean percentage change. Since mesor 
was highly positively correlated with amplitude (Spearman's rank correlation coefficient 
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0.95; p<0.001), regression analysis results were only presented for mesor. Phase delay 
was estimated as the adjusted geometric mean difference of the predicted acrophases in 
night workers compared to day workers. Light-at-night exposure, short-term (nights 
worked over the previous 2 weeks prior to urine collection) and long-term exposure 
(number of years worked in night shift) to night shift work were categorized using 
tertiles of exposure among night workers. Standard cut-off points for morningness-
eveningness (M-E) score were used to obtain a categorical variable for diurnal 
preference: evening (M-E score range: 26-41), neither (M-E score range: 42-58) and 
morning type (M-E score range: 59-67). Associations between aMT6s parameters and 
shift work were also tested stratifying by night shift workers´ diurnal preference, by 
tertiles of short-term, long-term and light-at-night exposure. Confounders were assessed 
using a Directed Acyclic Graph (DAG), shown in online supplemental materials (Figure 
1). On the basis of the DAG, all models were adjusted for potential confounders: age, 
diurnal preference (neither, evening, morning), education (primary school, secondary, 
university), sex (male, female), menopausal status (pre, post), parity (nulliparous, 1-2 
children, 3-4 children) and age of first birth (nulliparous, < 30 years, ≥ 30 years). 
Analyses were repeated using the criteria of 10% change in the coefficients for 
confounders’ selection. Estimates were slightly different from the simpler models, but 
differences did not follow a common pattern. Results of this analysis are presented in 
the online supplements (Table 1 and Table 2). A sensitivity analysis was performed by 
removing 4 subjects for whom the aMT6s cosinor fit was not significant (p >0.05) or 
the percentage of rhythm was low (< 50%) and 2 subjects with extreme aMT6s 
acrophases and results remained unchanged. All analyses were performed using 
statistical package Stata version 12.1 (StataCorp LP, Texas, USA). 
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RESULTS 
Basic sociodemographic and lifestyle characteristics of day and night shift workers are 
shown in Table 1. Night shift workers were older (mean (SD); 44.3 (10.4) vs 41.6 (9.5) 
years), less educated (83.3 of high school or higher vs 92.7%), more frequently evening 
types (22.2 vs 12.2%) and slept less on working days (5.9 vs 6.4 hours), compared to 
day workers. No differences in BMI, physical activity, alcohol or caffeine consumption 
over the last 24 hours were found between the two groups. Night workers reported more 
frequently the use (23.6 vs 9.8%) of medications that can affect melatonin 
(antidepressants, NSAIDS, beta blockers, calcium channel blockers) or a chronic illness 
(50 vs 26.4%), including high cholesterol, hypertension, thyroid disease, allergy, asthma 
and depression. A lower percentage of female night workers were premenopausal (48.5 
vs 80%), nulliparous (9.7 vs 20 %) and had their first full term birth before 30 years of 
age (70 vs 80%) compared to day workers. Night shift workers at the time of their 
participation had worked on average 2.4 (SD 1.1) consecutive nights (2.1 in the 
hospitals and industry, and 3.7 in the train company), 6.1 nights (SD 2.2) over the past 
two weeks and had been engaged in a total of 12.9 years (SD 10) of night shift work. 
Table 2 shows the description of light exposure over different periods in day and night 
shift workers. From 24:00 to 05:00 night shift workers were exposed to a median light 
intensity of 38 lux (IQR 26) which was mostly generated from overhead fluorescent 
lamps. Mean light exposures over the night shift ranged from 15–246 lux but intensities 
were similar across the 3 working sectors. 
Figure 1 shows the mean aMT6s cosinor curves and Table 3 the description of 
the cosinor derived parameters in day and night workers. The aMT6s mesor was lower 
among night workers (10.9 ng /mg creatinine) compared to day workers (15.4 ng/mg 
creatinine) over a 24 hour working day. On average the aMT6s peak time occurred 3 
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hours later in night workers (08:42 h, 95% CI 07:48, 09:42) compared to day workers 
(05:36 h, 95% CI 05:06, 06:12). Peak time was more delayed in male night shift 
workers (9:54; 95% CI 8:42, 11:30) and particularly among workers in the railway 
company (10:17; 95% CI 9:02, 11:42). We found a small positive correlation between 
aMT6s levels and acrophase among night shift workers (Pearson correlation coefficient 
0.23, p<0.05) over 24 hours. 
The associations between aMT6s cosinor parameters and night shift work, night 
shift workers’ diurnal preference, nights worked over the past 2 weeks and years 
worked night shifts among night shift workers are shown in Table 4. After adjusting for 
potential confounders, night shift workers had 33.8% (95% CI -48.4, -15.1) lower 
aMT6s levels compared to day workers.  The corresponding decreases in the hospitals, 
car industry and railway company workers were -38.3% (-55.2, -15.2), -36.3% (-56.5, -
6.7) and -17.1% (-44.3, 23.5) respectively. In night shift workers the aMT6s peak 
occurred significantly later (3 hours, p<0.001) than in day workers. The corresponding 
delay in the hospital, car industry and railway company workers was 2.0 (0.4, 3.6), 3.8 
(1.5, 6.1) and 4.6 hours (2.0, 7.2) respectively. Night shift workers with morning 
preference had 53.7 % lower aMT6s levels (p<0.001) while this reduction was 23.0% 
and 26.9% for night shift workers with evening and neither preference (p<0.001), 
respectively, compared to day workers. Diurnal preference did not modify the 
association between night shift work and aMT6s acrophase and all night shift workers 
had approximately 3 hours phase delay compared to day workers across the three 
groups of diurnal preference (p<0.05). By contrast, in day workers, aMT6s peak time 
was earlier in morning types (5:12 (4:36-5:48) compared to neither (5:36 (4:54-6:30) 
and evening types (6:42 (6:00, 7:36). As with night workers, aMT6s levels differed by 
diurnal preference among day workers. Mesor was 22.4 ng/mg creatinine/h (95% CI 
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13.9, 50.3) for day workers with evening preference, 15.5 (95% CI 11.7, 20.6) with 
neither and 10.5 (95% CI 7.4, 14.7) with morning preference.  
When evaluating aMT6s levels by the number of nights worked over the 
previous 2 weeks, subjects with ≤4 nights had a 40.6% (95% CI -56.4, -19.1) lower 
aMT6s levels compared to day workers whereas subjects with ≥9 nights had a decrease 
of 22.9% (95% CI -50.8, 21.0), suggesting a phase shift among subjects with more 
nights worked, compared to day workers (Table 4). Indeed the higher the number of 
night shifts performed over the previous two weeks the later the time of aMT6s peak 
phase delay; 3.3 hours (95% CI 1.6, 5.1)  among those with ≤4 nights and 3.7 hours 
(95% CI 0.9, 6.5) among those with ≥9 nights worked. Long-term exposure to night 
shift work was associated with lower aMT6s levels with the highest exposed group (>20 
yrs) showing a 43.9% decrease in aMT6s levels (95% CI -62.4, -16.3).  
As shown in Table 5 aMT6s levels were 30%, 36% and 35% lower in night 
workers in the first, second and third tertile of 24:00 to 05:00 h light exposure 
respectively, compared to day workers (p<0.05). Night shift workers in the second and 
third tertile of 24:00 to 05:00 h light exposure had a 3.7 hour delay (p<0.001) while 
those in the first tertile a 1.7 hour delay (p=0.008), compared to the day workers, 
however, differences between groups of light exposure were not statistically significant. 
Night shift workers in the top tertile of light exposure at work had a 37.7% decrease 
(p=0.005) and 3.2 hours of a delay (p<0.001), whereas those in the lowest tertile a 
27.3% decrease (p=0.060) and 2.5 h delay (p=0.003) in their acrophase, compared to 
day workers. Similar results were observed when the aMT6s parameters were compared 
with 22:00 to 07:00 h light exposure and morning light exposure (results not shown). 
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We adjusted all light-at-night models for morning light to account for sunlight 
exposure immediately after the night shift and results remained unchanged. Furthermore 
all models in Table 4 were adjusted for light-at-night exposure in an additional analysis 
and effects became stronger. All analyses were repeated excluding subjects with 
reported chronic diseases. Results (not shown) were similar to those of the main 
analysis.  
 
DISCUSSION 
Circadian aMT6s variation was evaluated in night and day shift workers over a 
24 hour period on a working day. Lower aMT6s levels and later peak times were found 
among permanent night workers compared to day workers. Differences in aMT6s levels 
were more pronounced in night shift workers with morning preference, whereas a 
delayed aMT6s peak time was associated with a higher light-at-night exposure and 
number of nights worked. 
These results are in agreement with some (11-17) but not all (18, 19, 30-32) 
previous studies, showing a reduction of aMT6s levels related to night shift work. 
Grundy et al (19) found non-significant aMT6s differences between the day and night 
shift among female nurses working on a rapid rotating shift schedule. Authors suggested 
that only 2 consecutive nights may not be enough for a disruption to be observed. Davis 
et al. (11) reported a 69% decrease in aMT6s levels during the night working period and 
a 63% decrease during the daytime sleep period among female health care night shift 
workers performing more than 2 consecutive nights per week. We found lower aMT6s 
levels among subjects that worked in schedules with less consecutive nights (hospitals, 
car industry). However, all participants in our study were engaged in fixed night shifts 
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and might represent a group with extreme exposure among the existing shift schedules 
and thus more likely to experience detectable biological changes. 
Previous studies have lacked melatonin acrophase assessment, therefore small 
phase shifts would not have been detected. In the present study, a 3 hour phase delay in 
aMT6s peak time was observed among night shift workers suggesting an overall partial 
shift adaptation, which was larger among males. Sex differences in the current study 
largely represent differences in the working sectors and the respective night shift 
schedules (start and stop times, hours of work, night shift work intensity, number of 
consecutive nights, number of days off) and related habits (e.g sleep, light exposure, 
timing of meals, social activities). Adaptation was more pronounced among night 
workers with more nights worked (railway company and industry), with aMT6s peaking 
during their reported sleep (average onset 07:00-08:00 h). Most hospital night workers 
exhibited a aMT6s peak before their average reported sleep onset (08:00-09:00 h) and 
around the end of their night shift. It has been suggested that some of the adverse effects 
of night shift work (sleepiness and work-related accidents) may be reduced if circadian 
adaptation occurred, such that a better alignment of circadian timing with the new sleep-
wake pattern is achieved (33, 34). However, even among permanent night shift workers 
several consecutive nights or weeks of night shift work appear to be required for full 
adaptation (aMT6s phase delay) to occur (21, 35). In the present study, we found a 
smaller decrease in aMT6s levels among workers with a higher number of night shifts 
that may suggest a rhythm phase delay due to partial adaptation. We also found a 
positive association between aMT6s mesor and acrophase among night workers. It is 
possible that the effect of light at night on melatonin levels is stronger among less 
adapted night workers or subjects with an earlier aMT6s peak time.  
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Long-term exposure to night shift work was also associated with lower levels of 
melatonin in our study. Chronic melatonin suppression has been linked to both initiation 
and promotion of cancer, since melatonin is a hormone with oncostatic properties (4, 6, 
36, 37). However, the anti-cancer effects of melatonin depend on the circadian stage, as 
suggested by animal studies (reviewed in (38)). Therefore, nocturnal timing of 
melatonin rhythm might be as important as absolute levels produced on a daily basis for 
its oncostatic role to be expressed and maintained. It is still unknown if partial phase 
shifts (3 hours) as described here can increase cancer risk in humans and future studies 
should consider possible rhythm changes when assessing night shift work related 
circadian disruption. 
In this study, subjects with morning preference had lower melatonin levels, 
compared to those with evening preference. To date, evidence is mixed for the 
association between diurnal preference and aMT6s levels in shift workers (19, 39) as 
well as non-shift workers (40, 41). Morning preference has been associated with an 
earlier melatonin peak time (26, 27, 39, 42). Individual circadian phase assessed by 
melatonin timing (21, 25) and chronotype have been associated with workers 
adaptability to shift-work schedules (24). Evening-types report better tolerance for night 
work and quicker adaptation (shift of the circadian rhythms) than morning types (20). 
We did not find an association between diurnal preference and aMT6s acrophase in 
night shift workers, as we had expected, perhaps because we lacked subjects with 
extreme morning or evening preferences, or due to low numbers. Very little is known 
about the association between chronotype and cancer risk (43). Chronotype has been 
suggested as a possible effect modifier for the night shift work-cancer association (43, 
44). Our findings provide evidence that subjects with morning preference might be a 
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group more susceptible to light-at-night effects and night shift work related circadian 
disruption. 
Lower aMT6s levels and later acrophases were found  among night shift workers 
compared to day workers despite low light exposure at work (<38 lux). In experimental 
studies, light-at-night suppresses melatonin in a dose-response manner, however, even 
low intensities of light exposure (100 lux) are able to both suppress and phase shift the 
human melatonin rhythm (8). Not only intensity but also timing of light exposure is 
important for the direction of the aMT6s phase shift, as described by the phase-response 
curve (45, 46). We examined the phase shifting abilities of light exposures occurring 
during the night shift but also tested the time period immediately after the shift and up 
to initiation of sleep and results were similar when morning light was taken into 
account. A few observational studies have included light measurements in their 
assessments. Only one study evaluated 24 hour melatonin production and monitored 
personal light exposure simultaneously including 13 rotating night workers (18). Light- 
at-night exposure at work (median 73 lux) did not have an effect on night time 
melatonin production although it reduced total 24 hour melatonin output. Our results are 
in agreement with this study; we additionally found a phase delay among night workers 
that was stronger with higher light exposures. The light loggers we used, however, may 
provide lower estimates compared to calibrated powermeters, particularly for low 
intensities of light (Peter Morgan, PhD Thesis, University of Surrey 2011).  
One of the strengths of the present study is the use of repeated aMT6s 
measurements over a 24 hour period which enabled the assessment of the peak time of 
melatonin production. Comparisons are not likely to have been confounded by inter-
individual variation in circadian phase, a main limitation in existing shift work studies. 
Furthermore, participants of both sexes and from 3 different occupational settings were 
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recruited, thus increasing the external validity of the results. Potential confounders were 
carefully selected in this analysis and the effect of night shift work on melatonin did not 
change substantially after adjustment.  In this study, however, due to its cross-sectional 
design, we cannot rule out the possibility that subjects who engaged in night shift work 
had lower baseline levels of aMT6s compared to day workers for other non-night shift 
work related reasons. An additional strength of this study is the assessment of individual 
light exposure using objective light measurements. The light monitors we used 
measured light intensity but not wavelength (e.g. blue light),  an aspect of light that 
might be important for melatonin suppression and circadian resetting (47, 48). The 
characterization of diurnal preference is a final strength of this study. We used the 
Horne-Östberg questionnaire, a validated instrument but designed for the general 
population. Future studies could consider the use of the Munich Chronotype 
Questionnaire (MCTQ) and its extended version (MCTQShift), to assess chronotype in 
night and rotating shift workers (49). 
In conclusion, this study evaluated the association of night shift work and 
individual characteristics with melatonin production and timing, the main mechanism 
proposed to underlie the association between night shift work and cancer risk. Our 
findings show that exposure to permanent night shift work is associated with lower 
aMT6s levels and a phase delay in aMT6s peak time compared to day workers, even 
under low intensities of light at night. This study also provides new evidence indicating 
that night shift work might have a greater impact on melatonin production among 
morning types.  
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 Table 1. Characteristics of the study population (N=113) 
 Day shift (N=41)  Night shift (N=72)  
Age (yrs); mean (SD) 41.6 (9.5)  44.3 (10.4)  
BMI (kg/m2); mean (SD) 25.2 (4.1)  25.6 (4.2)  
Participating companies (%)      
Hospital A 22.0  29.2  
Hospital B 24.4  20.8  
Car industry 29.3  25.0  
Railway company 24.4  25.0  
Female sex (%) 48.8  45.8  
Premenopausal (%)a 80.0  48.5b  
Nulliparous (%)a 20.0  9.7  
Age first child >30yrs (%)a 20.0  30.3  
Highest education completed (%)     
Primary school 7.3  16.7  
High school 51.2  43.0  
University 41.5  40.3  
Diurnal preference (%)     
Evening type  12.2  22.2  
Neither type  68.3  68.1  
Morning type  19.5  9.7b  
Current smokers (%) 36.6  31.9  
Chronic illness (%) 26.4  50.0b  
Drug use (antidepressants, NSAIDS, beta  
blockers & calcium channel blockers) (%) 
9.8  23.6b  
Sleep problems (%) 90.2  94.4  
Sleep duration on a working day (h); mean (SD) 6.4 (0.9)  5.9 (1.4)b  
Sleep duration on a day off (h); mean (SD) 8.1 (0.8)  8.2 (1.5)  
Habits over the last 24-h; mean (SD)     
Alcohol consumption (grams) 1.3 (3.9)  2.8 (7.3)  
Total caffeinated beverages (n) 2.9 (2.1)  2.5 (1.9)  
Physical exercise (METS*hrs) 18.3 (10.4)  14.9 (9.6)  
aPercentages are calculated among female day (n=20) and night (n=33) shift workers,  
bp<0.05 (chi-square for categorical and t-test for continuous variables) 
  
 Table 2. Average light exposure in day and night workers 
 Day shift (N=41)  Night shift (N=72) 
 Mean (sd) Median (iqr)  Mean (sd) Median (iqr) 
24h light exposure (lux) 1061 (881) 834 (675)  996 (1735) 441 (1222) 
Light-at-night exposure (lux)      
from 24:00 to 05:00 h 10 (19) 1 (10)  51 (49) 38 (26) 
from 22:00 to 07:00 h 57 (64) 30 (65)  192 (297) 43 (43) 
Light exposure at work (lux)a      
All sectors 1250 (1517) 784 (1142)  60 (46) 43 (38) 
Hospitals 822 (691) 640 (787)  64 (49) 47 (47) 
Car industry 1342 (1730) 872 (783)  69 (24) 44 (59) 
Railway company 1950 (2160) 1544 (1815)  43 (18) 39 (12) 
Morning light after work (lux)b - -  660 (1268) 221 (565) 
a Estimation based on start  and end time of work for each participant, b Estimation based on end time of 
night shift and time of sleep onset on working days for each participant 
 
 
 
 
  
  
Table 3. Description of aMT6s cosinor derived parameters: mesor (circadian mean), 
amplitude (difference between maximum and mesor) and acrophase (time of peak) in the 
study population 
 
  Crude geometric mean (95%CI) 
 N Mesora Amplitudeb Acrophasec 
All subjects     
Day workers 41 15.4 (12.3, 19.3) 15.4 (11.2, 21.0) 5:36 (5:06, 6:12) 
Night workers 72 10.9 (9.5, 12.6)d 10.9 (9.0, 13.4)d 8:42 (7:48, 9:42)e 
Hospitals 36 11.6 (9.4, 14.3)d 11.4 (8.4, 15.3) 7:42 (6:30, 9:12)d 
Car industry 18 9.2 (7.0, 12.0)d 10.0 (6.7, 14.9)d 9:31 (7:03, 12.18)e 
Railway company 18 11.6 (8.2, 16.4) 11.2 (7.5, 16.9) 10:17 (9:02, 11:42)e 
Females     
Day workers 20 17.1 (11.7, 25.1) 16.1 (9.1, 28.5) 5:54 (4.48, 7:12) 
Night workers 33 11.4 (9.2, 14.2)d 10.9 (8.0, 15.0)d 7:24 (6:12, 8:48)e 
Males      
Day workers 21 14.0 (10.6, 18.3) 14.7 (10.4, 20.6) 5:24 (4:54, 5:48) 
Night workers 39 10.5 (8.6, 12.9)d 10.9 (8.5, 14.3)d 9:54 (8:42, 11:30)e 
aExpressed in ng/creatinine/h, bExpressed in ng/creatinine, cExpressed as local time, dp<0.05 using the 
Wilcoxon rank-sum test, ep<0.001 using the Wilcoxon rank-sum test 
 
 
 Table 4. Estimated aMT6s mesor (circadian mean) and acrophase (peak time) by night shift work (shift status, night shift workers´ diurnal 
preference, nights worked over the past 2 weeks and total years worked in night shift work) 
    Mesor Acrophase 
  N  
Crude geometric 
mean (95%CI)a 
Adjusted mean 
% change (95%CI)b 
p-valuec 
Crude geometric 
mean (95%CI)d 
Adjusted mean 
difference (95%CI)b
p-valuec 
Day workers  41  15.4 (12.3, 19.3) Ref  5:36 (5:06, 6:12) Ref  
Night workers  72  10.9 (9.5, 12.6) -33.8 (-48.4, -15.1) <0.001 8:42 (7:48, 9:42) 3.0 (1.8, 4.2) <0.001 
Night shift workers´s diurnal preference     
Evening  16  11.8 (8.7, 15.8) -23.0 (-46.8, 11.5) <0.001 8:30 (5:48, 12:24) 3.0 (1.0, 5.1) 0.002 
Neither  49  11.5 (9.7, 13.6) -26.9 (-44.3, -4.1)  <0.001 8:48 (7:48, 9:54) 3.1 (1.7, 4.4) <0.001 
Morning  7  6.4 (3.0, 13.6) -53.7 (-72.2, -22.9) <0.001 8:30 (6:30, 11.18) 3.3 (0.3, 6.4) 0.012 
Nights worked over the past 2 weeks     
≤4 nights  27  10.5 (8.6, 12.9) -40.6 (-56.4, -19.1) 0.001 8:48 (7:42, 10:00) 3.3 (1.6, 5.1) <0.001 
5-8 nights  35  11.1 (8.8, 13.9) -30.1 (-48.1, -5.8) 0.019 7:18 (5:30, 9:48) 2.5 (1.0, 4.0) 0.001 
≥9 nights  10  11.6 (6.9, 19.5) -22.9 (-50.8, 21.0) 0.255 10:06 (7:36, 11:54) 3.7 (0.9, 6.5) 0.003 
Total years worked in night shift work     
≤9 yrs  36  11.7 (9.6, 14.4) -34.6 (-50.8, -12.9) 0.004 9:12 (7:30, 11:12) 3.2 (1.7, 4.8) <0.001 
10-19 yrs  16  10.6 (7.2, 15.8) -24.6 (-47.7, 8.6) 0.127 9:00 (7:42, 10:30) 3.6 (1.4, 5.8) <0.001 
≥20 yrs  20  9.8 (7.6, 12.7) -43.9 (-62.4, -16.3) 0.005 7:42 (6:24, 9:06) 1.7 (-0.3, 3.7) 0.079 
aExpressed in ng/creatinine/h, bAdjusted for age, chronotype, educational level, sex, menopausal status, parity, age at first full-term birth, cWald test,  
dExpressed as local time 
  
 Table 5. Estimated aMT6s mesor (circadian mean) and acrophase (peak time) by light exposure among night shift workers (tertiles of mean 
light exposure from 24:00 to 05:00 h and over the night shift)  
 
    Mesor  Acrophase 
  N  
Crude geometric 
mean (95%CI)a 
Adjusted mean 
% change (95%CI)b 
p-valuec  
Crude geometric 
mean (95%CI)d 
Adjusted mean 
difference (95%CI)b 
p-valuec 
Day workers  41  15.4 (12.3, 19.3) Ref   5:36 (5:06, 6:12) Ref  
Night workers  72  10.9 (9.5, 12.6) -33.8 (-48.4, -15.1) <0.001  8:42 (7:48, 9:42) 3.1 (1.8, 4.4) <0.001 
Mean light-at-night exposure from 24:00 to 05:00 h (lux)  
≤14  24  11.4 (8.8, 14.8) -30.3 (-49.9, -3.1) 0.032  7:12 (5:36, 9:00) 1.7 (0.1, 3.3) 0.008 
15-40  24  10.7 (8.4, 13.5) -36.3 (-54.6, -10.7) 0.009  9:18 (8:00, 10:48) 3.7 (1.8, 5.6) <0.001 
41-315  24  10.7 (8.0, 14.4) -35.0 (-53.0, -10.0) 0.010  9:48 (7:48, 12:06) 3.7 (1.8, 5.5) <0.001 
Mean light-at-night exposure over the night shift (lux)  
<38  24  11.3 (8,7,14.7) -27.3 (-47.8, 1.3) 0.060  8:06 (6:18, 10.:24) 2.5 (0.8, 4.3) 0.003 
38-55  24  10.3 (8.2, 13.0) -35.3 (-53.1, -10.8) 0.008  10:18 (8:18, 13:00) 3.2 (1.4, 5.0) <0.001 
55-246  24  11.2 (8.3, 15.0) -37.7 (-55.1, -13.6) 0.005  9:12 (7:18, 11:30) 3.2 (1.4, 5.0) <0.001 
aExpressed in ng/creatinine/h, bAdjusted for age, chronotype, educational level, sex, menopausal status, parity, age at first full-term birth, cWald test, dExpressed as 
local time  
  
 Figure 1. Graphic illustration of the cosinor curves and the derived parameters: mesor (m=circadian mean), amplitude (amp=distance between 
the maximum and mesor) and acrophase (t=peak time) in day and night workers 

